Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07426458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ventilation and Perfusion in Asthmatics

StatusRecruiting
PhasePhase 4
Started2026-04-27
View on ClinicalTrials.gov ↗

Amendment history

2026-04-30
Study Status, Contacts/Locations v3
Recruitment opened
Start dateestimated 2026-04→confirmed 2026-04-27
Study sitesdetails revised at 1 of 1 site
2026-04-01
Study Status, Arms and Interventions, Outcome Measures v2
InterventionsBudesonide/Formoterol (Drug), Formoterol (Drug)→Albuterol Sulfate (Drug), Albuterol-Budesonide (Drug)
Secondary endpointsdetails revised at 2 of 4 entries
2026-03-12
Study Status v1
Primary completion date2028-03→2028-04
Completion date2028-03→2028-04
Start date2026-03→2026-04
2026-02-20
Original filing
University of Miami
241 trials monitored
See 29 trials at risk
Asthma
918 trials monitored
See 29 trials at risk
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Trial Details
NCT Number NCT07426458
Lead Sponsor University of Miami
Collaborators: Australian Lung Health Initiative Pty Ltd
Conditions Asthma
Enrollment 40 participants
Start Date 2026-04-27
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-05